Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Specific PPAR gamma agonists may have different effects on cancer incidence.

Bambury RM, Iyer G, Rosenberg JE.

Ann Oncol. 2013 Mar;24(3):854. doi: 10.1093/annonc/mdt003. No abstract available.

2.

PPAR-gamma-agonists' renal effects.

Izzedine H, Launay-Vacher V, Buhaescu I, Heurtier A, Baumelou A, Deray G.

Minerva Urol Nefrol. 2005 Dec;57(4):247-60. Review.

PMID:
16247347
3.

Illuminating the diabetes-cancer link.

Brower V.

J Natl Cancer Inst. 2012 Jul 18;104(14):1048-50. doi: 10.1093/jnci/djs322. Epub 2012 Jul 9. No abstract available.

4.

Safety of PPAR agonists.

Home P.

Diabetes Care. 2011 May;34 Suppl 2:S215-9. doi: 10.2337/dc11-s233. No abstract available.

5.

Pioglitazone causing urinary bladder cancer? While waiting for the result of the debate, suggestions for physicians.

Cagiltay E, Tuncel T, Yönem A, Ozdemir G.

Eur J Intern Med. 2013 Mar;24(2):e21-2. doi: 10.1016/j.ejim.2012.12.002. Epub 2012 Dec 23. No abstract available.

PMID:
23267737
6.

A second chance for a PPARγ targeted therapy?

Norris AW, Sigmund CD.

Circ Res. 2012 Jan 6;110(1):8-11. doi: 10.1161/RES.0b013e3182435d88. No abstract available.

7.

Peroxisome proliferator-activated receptor-gamma agonists for management and prevention of vascular disease in patients with and without diabetes mellitus.

Ríos-Vázquez R, Marzoa-Rivas R, Gil-Ortega I, Kaski JC.

Am J Cardiovasc Drugs. 2006;6(4):231-42. Review.

PMID:
16913824
8.

Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes.

DREAM On (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication Ongoing Follow-up) Investigators, Gerstein HC, Mohan V, Avezum A, Bergenstal RM, Chiasson JL, Garrido M, MacKinnon I, Rao PV, Zinman B, Jung H, Joldersma L, Bosch J, Yusuf S.

Diabetologia. 2011 Mar;54(3):487-95. doi: 10.1007/s00125-010-1985-4. Epub 2010 Nov 30.

PMID:
21116607
9.

Releasing the pressure.

Davenport RJ.

Sci Aging Knowledge Environ. 2005 Jun 22;2005(25):nf47. No abstract available.

PMID:
15975897
10.

Diabetes and heart failure: the role of thiazolidinediones in managing these partners in crime.

Leier CV, Haas GJ.

J Am Coll Cardiol. 2007 Jul 3;50(1):37-9. Epub 2007 Jun 18. No abstract available.

11.

[Diabetes, heart, and glitazones].

Philippe J.

Rev Med Suisse Romande. 2004 Mar;124(3):133-5. Review. French. No abstract available.

PMID:
15095655
12.

1. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands and their therapeutic utility.

Henke BR.

Prog Med Chem. 2004;42:1-53. Review. No abstract available.

PMID:
15003718
13.

Rosiglitazone (Avandia) revisited.

[No authors listed]

Med Lett Drugs Ther. 2010 Mar 8;52(1333):17. No abstract available.

PMID:
20300053
14.

Thiazolidinediones: antidiabetic drugs with cardiovascular effects.

Pastromas S, Koulouris S.

Hellenic J Cardiol. 2006 Nov-Dec;47(6):352-60. Review. No abstract available.

15.

Diabetes expert accuses drug company of "intimidation".

Burton B.

BMJ. 2007 Dec 1;335(7630):1113. No abstract available.

16.

Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus.

Hanyu H, Sato T, Kiuchi A, Sakurai H, Iwamoto T.

J Am Geriatr Soc. 2009 Jan;57(1):177-9. doi: 10.1111/j.1532-5415.2009.02067.x. No abstract available.

PMID:
19170800
17.

PPAR agonists for the treatment of cardiovascular disease in patients with diabetes.

Wilding JP.

Diabetes Obes Metab. 2012 Nov;14(11):973-82. doi: 10.1111/j.1463-1326.2012.01601.x. Epub 2012 Apr 23. Review.

PMID:
22443197
18.

Pioglitazone may offer therapeutic advantages in diabetes-related atrial fibrillation.

Liu C, Liu T, Li G.

Int J Cardiol. 2013 Sep 30;168(2):1603-5. doi: 10.1016/j.ijcard.2013.01.037. Epub 2013 Feb 12. No abstract available.

PMID:
23414743
19.

[The PPARgamma receptor agonists and prevention of cardio-vascular complications in patients with type 2 diabetes. The results of the PROactive study].

Szymborska-Kajanek A, Strojek K.

Kardiol Pol. 2006 Mar;64(3):322-5; discussion 325-6. Review. Polish. No abstract available.

20.

PPARgamma agonists: killing two birds with one stone?

Ritz E.

J Hypertens. 2004 Sep;22(9):1673-4. Review. No abstract available.

PMID:
15311092
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk